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Scientists expressed relief at
President Bush’s long-awaited
decision to permit limited
federally funded research on
human embryonic stem cells,
but many questions remain,
reports Laura Bonetta.
In a short speech aired on national
television on August 9, US President
George W. Bush announced that the
National Institutes of Health (NIH)
will be allowed to fund work with
human embryonic stem (ES) cell
lines — but only if the work
involves lines that were established
before the president’s
announcement. The decision was
greeted with measured optimism by
many scientists, who await further
details about the existing ES cell
lines and the process for obtaining
them.
Bush’s decision will replace
guidelines crafted under the Clinton
administration, which never went
into effect. They did not permit the
use of federal funds to destroy
human embryos but would have
allowed federally funded scientists to
carry out studies involving ES cells
obtained from privately funded
researchers who had derived the cells
from surplus embryos to be discarded
by fertility clinics.
The new rules are more
restrictive in that federal funding will
be permitted only for research on cell
lines that are already established.
Stem cell lines derived after 9 August
will not be available for funding,
according to an NIH spokesperson.
In his speech, President Bush said he
had concluded to allow federal funds
to be used for research on the
existing ES cell lines “where the life
and death decision has already been
made.”
According to Bush, there are
60 ES cell lines in existence today.
The number came as a surprise to
most scientists working in the field,
many of whom are skeptical. “No
one I know is clear where the
number of 60 cell lines comes from.
It is certainly not true that there are
60 completely validated lines out
there,” says Janet Rossant of the
University of Toronto, Canada. 
An NIH spokesperson explained
that the NIH located the 60 plus
stem lines when staff carried out a
telephone survey of researchers and
companies in the US and abroad. Just
a month earlier, an NIH report on
stem cells estimated that only about
30 human ES cell lines existed. 
The US biotech company Geron
has reported having 5 ES cell lines, 3
of which have been extensively
characterized. In a press conference
held the day after the President Bush
address, Geron president and CEO,
Thomas Okarma, said that because
of the nature of stem cells — they
can replicate indefinitely — a limited
number would probably satisfy the
needs of the research community for
now.
At present, there is no way of
knowing how well characterized the
60 cell lines identified by NIH are
and how viable they will turn out to
be. The NIH is now in the process of
creating a ES cell lines registry. A
concern expressed by some scientists
is that many ES cell lines may have
commercial strings attached that
could limit research. 
Even if 60 viable cell lines do
exist, the number will not be
sufficient for any therapeutic
applications. According to Geron’s
senior vice president, David
Greenwood, when cell therapies
become available “we will want to
target patient populations as
precisely as we can. When that day
comes we will want to use multiple
cell lines.”
Despite these concerns and
uncertainties, many scientists were
relieved that Bush did not
altogether ban stem cell research.
The issue is likely to be disputed
further once Congress reconvenes in
September and it is possible that
Bush’s decision will be overruled.
Republican senator, Arlen Specter,
introduced a bill that would allow
NIH to fund derivation of new ES
cell lines, and a companion bill has
been introduced in the House of
Representatives. In a press release
Specter said “more than 60 stem cell
lines are necessary for scientific
research to be done now and
certainly what will be required in
the future.” 
In his August 9 speech, Bush also
announced the creation of a council
on bioethics to be chaired by Leon
Kass, an expert in biomedical ethics
and a professor at the University of
Chicago. The purpose of the new
council will be ‘to monitor stem cell
research, to recommend appropriate
guidelines and regulations and to
consider all of the medical and
ethical ramifications of biomedical
innovation.’
Laura Bonetta is a freelance science writer
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Stem cell moves: President Bush
announced his decision on ES cell research
funding in a televised address. “Many people
are finding that the more they know about
stem cell research,” Bush said, “the less
certain they are.” (Picture: AP)
